loadpatents
name:-0.054549217224121
name:-0.028759956359863
name:-0.0015490055084229
PROXIMAGEN LIMITED Patent Filings

PROXIMAGEN LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for PROXIMAGEN LIMITED.The latest application filed is for "new therapeutic compound and use in therapy".

Company Profile
2.37.66
  • PROXIMAGEN LIMITED - Cambridge Cambridgeshire GB
  • PROXIMAGEN LIMITED - Cambridge GB
  • PROXIMAGEN LIMITED - Cambridgeshire GB
  • Proximagen Limited - London N/A GB
  • Proximagen Limited -
  • Proximagen Ltd. - London GB
  • Proximagen Ltd - London GB
  • Proximagen Limited - Loondon GB
  • Proximagen Limited - GB GB
  • PROXIMAGEN LTD., - HODGKIN BUILDING, GUY'S CAMPUS KINGS COLLEGE LON LONDON GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
New Therapeutic Compound And Use In Therapy
App 20190185467 - PATIENT; Lee
2019-06-20
Substituted imidazo[4,5-c]pyridines as SSAO inhibitors
Grant 10,065,954 - Espensen , et al. September 4, 2
2018-09-04
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20180194763 - Espensen; Max ;   et al.
2018-07-12
New Compounds I
App 20180118744 - SAVORY; Edward ;   et al.
2018-05-03
Pharmaceutical Salt Forms Of An Inhibitor Of Semicarbazide-sensitive Amine Oxidase (ssao)
App 20180111928 - SAVORY; Edward ;   et al.
2018-04-26
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
Grant 9,951,068 - Espensen , et al. April 24, 2
2018-04-24
Treatment Of Pain
App 20180104223 - GONZALEZ; Isabel ;   et al.
2018-04-19
Crystalline Compound As Semicarbazide-sensitive Amine Oxidase (ssao) Enzyme Inhibitor
App 20180085357 - SAVORY; Edward
2018-03-29
Novel Therapies For Cancer
App 20180078563 - RICHARDSON; Peter ;   et al.
2018-03-22
Compounds I
Grant 9,890,160 - Savory , et al. February 13, 2
2018-02-13
Imidazo[4,5-c]pyridine Derived Ssao Inhibitors
App 20170362218 - Espensen; Max ;   et al.
2017-12-21
Imidazo[4,5-c]pyridine Derived Ssao Inhibitors
App 20170275281 - Patient; Lee ;   et al.
2017-09-28
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20170247378 - Espensen; Max ;   et al.
2017-08-31
CXCR4 Receptor Antagonists
App 20170226106 - Savory; Edward Daniel ;   et al.
2017-08-10
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
Grant 9,676,769 - Espensen , et al. June 13, 2
2017-06-13
Compounds
Grant 9,580,415 - Patient , et al. February 28, 2
2017-02-28
New Compounds I
App 20170044157 - Savory; Edward ;   et al.
2017-02-16
Pro-drug compounds
Grant 9,499,510 - Savory , et al. November 22, 2
2016-11-22
4,5,6,7-tetrahyroimidazo[4,5-c]pyridine compounds
Grant 9,493,457 - Savory , et al. November 15, 2
2016-11-15
New Compounds
App 20160326172 - Espensen; Max ;   et al.
2016-11-10
Prodrug Compounds
App 20160318892 - Savory; Edward ;   et al.
2016-11-03
Tonabersat Prodrugs
App 20160318891 - Savory; Edward ;   et al.
2016-11-03
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof
Grant 9,428,498 - Espensen , et al. August 30, 2
2016-08-30
CXCR4 receptor antagonists
Grant 9,353,086 - Savory , et al. May 31, 2
2016-05-31
Pro-drug Compounds
App 20160115147 - Savory; Edward ;   et al.
2016-04-28
New Therapeutic Uses Of Enzyme Inhibitors
App 20160113893 - Mulvany; Kenneth ;   et al.
2016-04-28
Therapeutic uses of enzyme inhibitors
App 20160101072 - Mulvany; Kenneth ;   et al.
2016-04-14
CXCR4 Receptor Antagonists
App 20160046606 - Savory; Edward Daniel ;   et al.
2016-02-18
Imidazo[4,5-c]pyridine And Pyrrolo[2,3-c]pyridine Derivatives As Ssao Inhibitors
App 20160046622 - Espensen; Max ;   et al.
2016-02-18
New Compounds
App 20160024080 - Patient; Lee ;   et al.
2016-01-28
Pro-drug Compounds
App 20160016929 - SAVORY; Edward ;   et al.
2016-01-21
Inhibitor compounds of semicarbazide-sensitive amine oxidases
Grant 9,227,967 - Evans , et al. January 5, 2
2016-01-05
Pro-drug Compounds
App 20150322034 - Savory; Edward ;   et al.
2015-11-12
Enzyme inhibitor compounds
Grant 9,150,574 - Evans , et al. October 6, 2
2015-10-06
New Compounds
App 20150258101 - Espensen; Max ;   et al.
2015-09-17
Alpha-7 nicotinic receptor modulators for the treatment of pain, a psychotic disorder, cognitive impairment or alzheimer'S disease
Grant 9,133,178 - Dean , et al. September 15, 2
2015-09-15
Imidazopyridine Compounds
App 20150239905 - Nilsson; Marianne ;   et al.
2015-08-27
New Compounds I
App 20150218161 - Savory; Edward ;   et al.
2015-08-06
Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compounds
Grant 9,035,066 - Savory , et al. May 19, 2
2015-05-19
Indole Derivative Modulators of the alpha 7 nAChR
App 20150038517 - Dinnell; Kevin
2015-02-05
Indole and azaindole modulators of the alpha 7 nAChR
App 20150005321 - Dinnell; Kevin ;   et al.
2015-01-01
New Enzyme Inhibitor Compounds
App 20140357623 - Evans; David ;   et al.
2014-12-04
(2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine And Salts Thereof
App 20140329826 - Fleck; Tom ;   et al.
2014-11-06
New Compounds
App 20140275040 - Espensen; Max ;   et al.
2014-09-18
New Enzyme Inhibitor Compounds
App 20140275063 - Carley; Allison ;   et al.
2014-09-18
Pro-drug Compounds
App 20140275068 - Savory; Edward ;   et al.
2014-09-18
Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseases
Grant 8,835,439 - Fleck , et al. September 16, 2
2014-09-16
Indole derivative modulators of the alpha 7 nAChR
Grant 8,829,031 - Dinnell September 9, 2
2014-09-09
Indole and azaindole modulators of the alpha 7 nachr
Grant 8,796,283 - Dinnell , et al. August 5, 2
2014-08-05
Imidazopyridine Compounds
App 20140206662 - Nilsson; Marianne ;   et al.
2014-07-24
New Compounds I
App 20140121219 - Savory; Edward ;   et al.
2014-05-01
New Compounds II
App 20140107150 - Savory; Edward ;   et al.
2014-04-17
Compounds for treatment or prevention of inflammation, an inflammatory disease, or an immune or an autoimmune disorder
Grant 8,633,318 - Savory , et al. January 21, 2
2014-01-21
Pro-drug Compounds
App 20140011773 - Savory; Edward ;   et al.
2014-01-09
Alpha-7 Nicotinic Receptor Modulators For The Treatment Of Pain, A Psychotic Disorder, Cognitive Impairment Or Alzheimer's Disease
App 20130310380 - Dean; David ;   et al.
2013-11-21
CXCR4 Receptor Antagonists
App 20130289020 - Savory; Edward Daniel ;   et al.
2013-10-31
Methods of using 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine compounds
Grant 8,569,338 - Savory , et al. October 29, 2
2013-10-29
7-hydroxy-pyrazolo[1,5-a] Pyrimidine Compounds And Their Use As Ccr2 Receptor Antagonists
App 20130252951 - Boyd; Joe William ;   et al.
2013-09-26
New Enzyme Inhibitor Compounds
App 20130102587 - Evans; David ;   et al.
2013-04-25
Indoles as modulators of nicotinic acetylcholine receptor subtype alpha-7
Grant 8,377,941 - Dinnell , et al. February 19, 2
2013-02-19
Amino acid derivatives
Grant 8,377,986 - Hobbs February 19, 2
2013-02-19
New Compounds I
App 20120302583 - Savory; Edward Daniel ;   et al.
2012-11-29
Indole And Azaindole Modulators Of The Alpha 7 Nachr
App 20120283273 - Dinnell; Kevin ;   et al.
2012-11-08
Indole modulators of the alpha 7 nicotinic acetylcholine receptor
Grant 8,283,365 - Dinnell , et al. October 9, 2
2012-10-09
4,5,6,7-tetrahydroimidazo[4,5-c]pyridine compounds
Grant 8,263,616 - Savory , et al. September 11, 2
2012-09-11
Amino acid derivatives
Grant 8,258,097 - Hobbs September 4, 2
2012-09-04
Sulfonyl-indole derivatives
Grant 8,138,333 - Angbrant , et al. March 20, 2
2012-03-20
New Compounds I
App 20110207746 - Savory; Edward Daniel ;   et al.
2011-08-25
New Compounds Ii
App 20110195992 - Savory; Edward ;   et al.
2011-08-11
Tricyclic compounds, compositions, and methods useful in the treatment or prophylaxis of 5-HT.sub.6 receptor-related disorders
Grant 7,960,374 - Brandt , et al. June 14, 2
2011-06-14
Compounds
Grant 7,943,639 - Johansson , et al. May 17, 2
2011-05-17
Treatment for neurodegeneration
Grant 7,790,687 - Iczkiewicz , et al. September 7, 2
2010-09-07
Amino Acid Derivatives
App 20100216878 - Hobbs; Christopher
2010-08-26
Amino Acid Derivatives
App 20100190725 - Hobbs; Christopher
2010-07-29
Amino Acid Derivatives
App 20090239941 - Hobbs; Christopher
2009-09-24
Amino Acid Derivatives
App 20090170937 - Hobbs; Christopher
2009-07-02
Inhibition or Treatment of Dyskinesia
App 20080070952 - Irvani; Mahmoud ;   et al.
2008-03-20
Treatment
App 20060264371 - Jenner; Peter ;   et al.
2006-11-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed